Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
CERo Therapeutics Holdings, Inc. (CERO) had Return on Tangible Equity of 365.75% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-95.53M |
|
-- |
|
-- |
|
$18.46M |
|
$-18.46M |
|
$-1.46M |
|
$-19.92M |
|
$-19.92M |
|
$-19.92M |
|
$-19.92M |
|
$-19.92M |
|
$-19.92M |
|
$-18.46M |
|
$-17.38M |
|
4.23M |
|
4.23M |
|
$-22.58 |
|
$-22.58 |
|
| Balance Sheet Financials | |
$2.73M |
|
$0.25M |
|
$0.91M |
|
$3.64M |
|
$9.09M |
|
-- |
|
-- |
|
$9.09M |
|
$-12.71M |
|
$-5.45M |
|
$-5.45M |
|
21.10M |
|
| Cash Flow Statement Financials | |
$-16.08M |
|
$0.50M |
|
$13.92M |
|
$3.33M |
|
$1.66M |
|
$-1.66M |
|
$1.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
156.73% |
|
|
Return on Tangible Equity |
365.75% |
-547.09% |
|
365.75% |
|
$-0.26 |
|
$-3.68 |
|
$-3.80 |
|